Next Generation Protein Therapeutics Summit

ACCELERATE PROMISING NEW MOLECULES INTO DIFFERENTIATED PRODUCTS

AbbVie, Amgen, Merck, AstraZeneca, and more will present top case studies and new data in the following areas:

Day 1: Novel Protein Engineering & Designs

• Applications of computational protein design and designing synthetic proteins
• See success in the clinic of these complex molecules and lessons learned for R & D
• Uncover creative engineering and design approaches for next generation protein therapeutics

Day 2: Overcoming Next Generation Protein Drug Challenges

• Are you up-to-date on the use of novel protein therapeutics for diseases outside of oncology?
• Overcome common protein drug challenges including efficacy, half-life and toxicity
• NEW: Examining analytical strategies for characterization, developability and stability

Day 3: Targets, ADCs & Future Concepts

• Discover the importance of identifying and utilizing new and more challenging targets
• How can delivery methods enhance the effectiveness of these drugs and what new approaches are being used?
• Share sessions with the bioconjugates audience to deliberate toxicity, stability and therapeutic window
• Looking ahead: What will be the next successful molecule?